Pain Symptomatology and Management in Pediatric Ehlers–Danlos Syndrome: A Review

Abstract

Ehlers–Danlos syndromes (EDS) are a group of connective tissue disorders that manifest with hyperextensibility of joints and skin, and general tissue fragility. While not a major criterion for clinical diagnosis, pain is a frequently endorsed symptom across subtypes of EDS. As such, the present review aims to summarize research to date on pain characteristics and management, and the relationship between such pain symptomatology and quality of life in pediatric EDS. Characteristics of pain, including theorized etiology, relative intensity and extent of pain are described, as well as descriptions of frequently endorsed pain sites (musculoskeletal, and non-musculoskeletal). Interventions related to the management of musculoskeletal (e.g., pharmaceutical intervention, physical therapy) and non-musculoskeletal pain (e.g., pharmaceutical and psychological interventions) are discussed, highlighting the need for additional research related to pediatric pain management in the context of hypermobility syndromes. In addition, the relationship between pain in pediatric EDS and quality of life is described. Finally, limitations of literature to date are described and recommendations for future lines of research are outlined.

Hepatoprotective effect of Thyme aqueous extract in Acetaminophen induces hepatotoxicity in male rats.

“…According to the histopathological severity score, the Acetaminophen group revealed severe toxicity, significantly different from the Control group, which revealed zero histopathological severity score. This histopathological result agrees with a study by Muhammad-Azam et al 18 . Studies by (19).…”

Masterclass: Hypermobility and hypermobility related disorders

“…Pharmacological management of pain in HSD/hEDS is beyond the scope of this masterclass. For further information about drug management readers are referred to recent papers by , Chopra et al, 2017, Feldman et al, 2020.…”

Ehlers-Danlos syndrome with damage to the digestive tract, heart, kidneys and other organs

“…По данным Malfait с соавт., с 1998 года были диагностированы новые генетические подтипы СЭД и в 2017 году была пересмотрена классификация СЭД и описаны 13 фенотипов СЭД, добавлены: новый подтип классического, сердечно-клапанный, синдром хрупкой роговицы, спондилодиспластический, мышечно-контрактурный, миопатический, пародонтальный. Гипермобильный и классический типы составляют 90% случаев СЭД [4,5] Полиорганность…”